tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
PremiumRatingsPositive Outlook on Contineum Therapeutics: Promising Pipeline and Strategic Collaborations Drive Buy Rating
2M ago
Contineum initiated with an Outperform at William Blair
Premium
The Fly
Contineum initiated with an Outperform at William Blair
2M ago
Premium
Ratings
Promising Developments at Contineum Therapeutics Signal Undervaluation and Favorable Risk-Reward
3M ago
Contineum names Timothy Watkins as Chief Medical Officer
PremiumThe FlyContineum names Timothy Watkins as Chief Medical Officer
3M ago
new option listings on April 9th
Premium
The Fly
new option listings on April 9th
4M ago
Premium
Company Announcements
Contineum Therapeutics Appoints Diego Miralles to Board
5M ago
Contineum price target lowered to $16 from $32 at Baird
PremiumThe FlyContineum price target lowered to $16 from $32 at Baird
5M ago
Contineum reports Q4 EPS (56c), consensus (44c)
Premium
The Fly
Contineum reports Q4 EPS (56c), consensus (44c)
5M ago
Contineum initiates dosing in phase 1b Chronic Pain trial of PIPE-791
Premium
The Fly
Contineum initiates dosing in phase 1b Chronic Pain trial of PIPE-791
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100